Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Scientific to Acquire Synlab's Spanish Clinical Dx Operations

NEW YORK – Eurofins Scientific announced Monday that it has agreed to acquire Synlab's clinical diagnostics operations in Spain for an undisclosed amount.

The transaction is subject to customary conditions and is expected to close in 2025.

Synlab provides clinical diagnostics testing, including genetics and anatomical pathology services, throughout Spain and achieved revenues of approximately €140 million ($151.4 million) in 2023. Eurofins' clinical diagnostic operations in Spain are led by Eurofins Megalab, which specializes in all types of clinical diagnostics testing and managing intra-hospital laboratories in Spain, the firm noted in a statement.

Once the transaction is completed, the combined company will have more than 2,000 employees, and the network of laboratories and blood collection points will have the capacity to process 100 million laboratory tests per year, Eurofins said.

"This acquisition confirms Eurofins' commitment to providing the best clinical diagnostic testing services to the Spanish market," Eurofins CEO Gilles Martin said in a statement. "It is our aim to always be the most trusted and technologically advanced partner of choice for our clients, providing high quality and accessible testing services to both the private and public sector, including regional healthcare services, private hospital groups, and insurance companies."

Earlier this year, Eurofins acquired California kidney dialysis testing firm Ascend Clinical.